322 related articles for article (PubMed ID: 16143683)
1. Diagnosis and disease modifying treatments in multiple sclerosis.
Zajicek J
Postgrad Med J; 2005 Sep; 81(959):556-61. PubMed ID: 16143683
[TBL] [Abstract][Full Text] [Related]
2. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
Correale J; Cristiano E
Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177
[TBL] [Abstract][Full Text] [Related]
3. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
4. [New approaches in research of therapy of multiple sclerosis].
Hemmer B; Cepok S; Nessler S; Sommer N
Med Klin (Munich); 2001 Sep; 96 Suppl 1():23-8. PubMed ID: 11603112
[TBL] [Abstract][Full Text] [Related]
5. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
7. [Recent therapeutic strategy for multiple sclerosis].
Itoyama Y
Rinsho Shinkeigaku; 2001 Dec; 41(12):1214-7. PubMed ID: 12235841
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer acetate (Copaxone).
Francis DA
Int J Clin Pract; 2001; 55(6):394-8. PubMed ID: 11501229
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
Goodin DS; Bates D
Mult Scler; 2009 Oct; 15(10):1175-82. PubMed ID: 19737851
[TBL] [Abstract][Full Text] [Related]
10. The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Goodin DS
Semin Neurol; 2013 Feb; 33(1):13-25. PubMed ID: 23709209
[TBL] [Abstract][Full Text] [Related]
11. [Rationale for an early treatment of multiple sclerosis].
Comi G; Martino G
Rev Neurol; 2000 Jun 16-30; 30(12):1265-8. PubMed ID: 10935262
[TBL] [Abstract][Full Text] [Related]
12. Early treatment.
Comi G
Neurol Sci; 2006 Mar; 27 Suppl 1():S8-12. PubMed ID: 16708191
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: interferon beta for some serious forms.
Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
Pula JH; Javed A
Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
[TBL] [Abstract][Full Text] [Related]
15. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
Neuhaus O; Stüve O; Archelos JJ; Hartung HP
J Neurol Sci; 2005 Jun; 233(1-2):173-7. PubMed ID: 15949504
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer and suspected multiple sclerosis. No proven advantage.
Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20941852
[No Abstract] [Full Text] [Related]
17. New options for early treatment of multiple sclerosis.
Tintoré M
J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
[TBL] [Abstract][Full Text] [Related]
18. [A short history of beta-interferon therapy of multiple sclerosis].
Stock G; Horowski R
Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
[TBL] [Abstract][Full Text] [Related]
19. Betaseron: a breakthrough treatment for multiple sclerosis.
Morrison W; Nelson J
Can Nurse; 1996 Oct; 92(9):38-41. PubMed ID: 9118060
[TBL] [Abstract][Full Text] [Related]
20. [Clinical surveillance of patients with multiple sclerosis].
Cazzato G; Zorzon M
Recenti Prog Med; 2003 Apr; 94(4):173-6. PubMed ID: 12677789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]